| Eric Kendall, PT, DPT | |
|
2707 171st Pl Ne Ste 101, Marysville, WA 98271-4740 | |
| (360) 386-7401 | |
| (360) 386-7402 |
| Full Name | Eric Kendall |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 2707 171st Pl Ne Ste 101, Marysville, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801389143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 5501018672 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Benchmark Physical Therapy Of Oregon Llc | 0143510602 | 83 |
News Archive
The US healthcare system needs to undergo further reform if racial disparities in pediatric surgical care are to be addressed, report researchers.
Cortex Pharmaceuticals, Inc. announced that it has regained worldwide rights to develop and commercialize its AMPAKINE® compounds for the treatment of schizophrenia and depression.
Ascalon International Inc., a newly established oncology drug developer, today announced an agreement for an exclusive option to license CerRx Inc's intravenous fenretinide product.
Recipients of the 10th annual Communication Awards were announced today by the National Academy of Sciences, National Academy of Engineering, and Institute of Medicine.
› Verified 6 days ago
| Entity Name | Benchmark Physical Therapy Of Oregon Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1801257191 PECOS PAC ID: 0143510602 Enrollment ID: O20160613001008 |
News Archive
The US healthcare system needs to undergo further reform if racial disparities in pediatric surgical care are to be addressed, report researchers.
Cortex Pharmaceuticals, Inc. announced that it has regained worldwide rights to develop and commercialize its AMPAKINE® compounds for the treatment of schizophrenia and depression.
Ascalon International Inc., a newly established oncology drug developer, today announced an agreement for an exclusive option to license CerRx Inc's intravenous fenretinide product.
Recipients of the 10th annual Communication Awards were announced today by the National Academy of Sciences, National Academy of Engineering, and Institute of Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Kendall, PT, DPT 2529 Central Ave Sw, Wyoming, MI 49519-2249 Ph: (269) 818-7359 | Eric Kendall, PT, DPT 2707 171st Pl Ne Ste 101, Marysville, WA 98271-4740 Ph: (360) 386-7401 |
News Archive
The US healthcare system needs to undergo further reform if racial disparities in pediatric surgical care are to be addressed, report researchers.
Cortex Pharmaceuticals, Inc. announced that it has regained worldwide rights to develop and commercialize its AMPAKINE® compounds for the treatment of schizophrenia and depression.
Ascalon International Inc., a newly established oncology drug developer, today announced an agreement for an exclusive option to license CerRx Inc's intravenous fenretinide product.
Recipients of the 10th annual Communication Awards were announced today by the National Academy of Sciences, National Academy of Engineering, and Institute of Medicine.
› Verified 6 days ago
Tyler Peter Klein, D.O. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2901 174th St Ne, Marysville, WA 98271 Phone: 360-454-1989 Fax: 360-454-1968 | |
Nicholas Wilcox, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2901 174th St Ne, Marysville, WA 98271 Phone: 360-454-1900 | |
Laura E Adams, LMT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1085 Cedar Ave, Marysville, WA 98270 Phone: 425-760-2372 Fax: 360-363-4168 |